StockWatch
·
Pharmaceuticals
Board Meeting23 Jul 2026, 04:28 pm

Hester Biosciences Board Meeting on July 30, 2026

AI Summary

Hester Biosciences Ltd has announced that its Board of Directors will convene on Thursday, July 30, 2026. The primary agenda item for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter that concluded on June 30, 2026. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has formally notified the BSE of this upcoming board meeting.

Key Highlights

  • Board meeting scheduled for July 30, 2026.
  • To consider unaudited financial results for Q1 FY27.
  • Results will include both standalone and consolidated figures.
  • Announcement made as per SEBI listing regulations.